← All organizations
First clinical trial
Jan 1, 2000Last known activity
Nov 1, 2005
Acquired by Abbott on Nov 6, 2006
Timeline
1980s
- Jul 1, 1988
Kos Pharmaceuticals— Founded
2000s
- Nov 6, 2006
Abbott— Acquired By
Drugs by trial phase (9 distinct, 10 trials)
Phase 4 (9 own, 0 via acquisition)
Indications
Studied for
- Atherosclerosis
- Carotid Artery Diseases
- Coronary Artery Disease
- Coronary Disease
- Dyslipidemias
- Heart Diseases
- Hypercholesterolemia
- Hyperlipidemia, Familial Combined
- Hyperlipidemias
- Hyperlipoproteinemias
- Insulin Resistance
- Intermittent Claudication
- Metabolic Syndrome
- Myocardial Ischemia
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Syndrome
- Vascular Diseases
Recent trials (10)
- NCT00300365CollaboratorPhase 4Nov 1, 2005
- NCT00082251Lead sponsorPhase 3May 3, 2004
- NCT00079638Lead sponsorPhase 4Apr 1, 2004
- NCT00080275Lead sponsorPhase 3Mar 1, 2004
- NCT00071266Lead sponsorPhase 3Oct 1, 2003
- NCT00345657CollaboratorPhase 4Jul 1, 2003
- NCT00062556Lead sponsorPhase 3Jan 1, 2003
- NCT00590629CollaboratorPhase 4Jun 1, 2002
- NCT00304993CollaboratorPhase 4Jan 1, 2001
- NCT00307307CollaboratorPhase 4Jan 1, 2000
Details
- Founded
- Cranbury, NJ, US Jul 1, 1988
- Last known activity
- Nov 1, 2005
Notes
Acquired by Abbott 6 Nov 2006